2018
Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors
Strosberg D, Schneider EB, Onesti J, Saunders N, Konda B, Shah M, Dillhoff M, Schmidt CR, Shirley LA. Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors. Annals Of Surgical Oncology 2018, 25: 3613-3620. PMID: 30182331, DOI: 10.1245/s10434-018-6741-x.Peer-Reviewed Original ResearchConceptsRepeat transarterial chemoembolizationMetastatic neuroendocrine tumorsTransarterial chemoembolizationPancreastatin levelsNeuroendocrine tumorsOverall survivalPrognostic impactImproved overall survivalProgressive liver diseaseFirst transarterial chemoembolizationWorse overall survivalUseful prognostic indicatorLong-term survivalPg/mLConclusionsFor patientsPost TACECarcinoid syndromeTACE treatmentLiver metastasesPatient demographicsImproved survivalLiver diseasePoor outcomePrognostic indicatorResultsA total
2016
Preventing anastomotic complications: early results of laparoscopic gastric devascularization two weeks prior to minimally invasive esophagectomy
Strosberg DS, Merritt RE, Perry KA. Preventing anastomotic complications: early results of laparoscopic gastric devascularization two weeks prior to minimally invasive esophagectomy. Surgical Endoscopy 2016, 31: 1371-1375. PMID: 27495339, DOI: 10.1007/s00464-016-5122-4.Peer-Reviewed Original ResearchConceptsLaparoscopic gastric devascularizationInvasive Ivor Lewis esophagectomyIvor Lewis esophagectomyNeoadjuvant chemoradiationAnastomotic leakAnastomotic complicationsAnastomotic strictureAnastomotic healingGastric conduit perfusionPost-operative nauseaMedian operative timeDay of surgeryLarge academic medical centerShort gastric vesselsAcademic medical centerConduit perfusionMediastinal inflammationHospital stayGastric arteryPatient demographicsEsophageal resectionPerioperative eventsRetrospective reviewComorbid conditionsOperative time